Adarx Pharmaceuticals 446.3 میلیون دلار در عرضه اولیه اولیه سهام ایالات متحده افزایش داد

Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO

Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.